-
1
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
-
West of Scotland Coronary Prevention Study Group
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
Isles, C.G.4
Lorimer, A.R.5
MacFarlane, P.W.6
McKillop, J.H.7
Packard, C.J.8
-
2
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
3
-
-
0032554688
-
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the cholesterol and recurrent events trial
-
(1998)
Circulation
, vol.97
, pp. 1446-1452
-
-
Sacks, F.M.1
Moye, L.A.2
Davis, B.R.3
Cole, T.G.4
Rouleau, J.L.5
Nash, D.T.6
Pfeffer, M.A.7
Braunwald, E.8
-
6
-
-
0033527030
-
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
-
Veterans Affairs High-density Lipoprotein Cholesterol Intervention Trial Study Group
-
(1999)
N Engl J Med
, vol.341
, pp. 410-418
-
-
Rubins, H.B.1
-
8
-
-
0025132245
-
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
-
(1990)
Nature
, vol.347
, pp. 645-650
-
-
Issemann, I.1
Green, S.2
-
15
-
-
0025697301
-
Efficacy of ciprofibrate in primary type II and IV hyperlipidemia: The Italian multicenter study
-
(1990)
Clin Ther
, vol.12
, pp. 482-488
-
-
Cattin, L.1
Da Col, P.G.2
Feruglio, F.S.3
Finazzo, L.4
Rimondi, S.5
Descovich, G.6
Manzato, E.7
Zambon, S.8
Crepaldi, G.9
Siepi, D.10
-
16
-
-
0025873036
-
Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozil
-
(1991)
J Intern Med
, vol.229
, pp. 427-434
-
-
Tilly-Kiesi, M.1
Tikkanen, M.J.2
-
20
-
-
7844237506
-
Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression
-
(1998)
Endocrinology
, vol.139
, pp. 4920-4927
-
-
Kelly, L.J.1
-
21
-
-
0021276830
-
Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man
-
(1984)
JAMA
, vol.251
, pp. 2241-2246
-
-
Kesaniemi, Y.A.1
Grundy, S.M.2
-
22
-
-
0029791412
-
PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
-
(1996)
EMBO J
, vol.15
, pp. 5336-5348
-
-
Schoonjans, K.1
Peinado-Onsurbe, J.2
Lefebvre, A.M.3
Heyman, R.A.4
Briggs, M.5
Deeb, S.6
Staels, B.7
Auwerx, J.8
-
24
-
-
0019138139
-
Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins
-
(1980)
J Biol Chem
, vol.255
, pp. 8303-8307
-
-
Windler, E.1
Chao, Y.2
Havel, R.J.3
-
25
-
-
0029018057
-
Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 963-971
-
-
Clavey, V.1
Lestavel-Delattre, S.2
Copin, C.3
Bard, J.M.4
Fruchart, J.5
-
26
-
-
0026443622
-
Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles
-
(1992)
J Clin Invest
, vol.90
, pp. 1889-1900
-
-
Aalto-Setala, K.1
Fisher, E.A.2
Chen, X.3
Chajek-Shaul, T.4
Hayek, T.5
Zechner, R.6
Walsh, A.7
Ramakrishnan, R.8
Ginsberg, H.N.9
Breslow, J.L.10
-
30
-
-
0026636624
-
Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3
-
(1992)
J Biol Chem
, vol.267
, pp. 15849-15860
-
-
Ladias, J.A.1
Hadzopoulou-Cladaras, M.2
Kardassis, D.3
Cardot, P.4
Cheng, J.5
Zannis, V.6
Cladaras, C.7
-
31
-
-
0032145190
-
Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids
-
(1998)
J Clin Invest
, vol.102
, pp. 625-632
-
-
Vu-Dac, N.1
Gervois, P.2
Pineda Torra, I.P.3
Fruchart, J.C.4
Kosykh, V.5
Kooistra, T.6
Princen, H.M.7
Dallongeville, J.8
Staels, B.9
-
32
-
-
0026631526
-
A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition
-
(1992)
Metabolism
, vol.41
, pp. 498-503
-
-
Bard, J.M.1
Parra, H.J.2
Camare, R.3
Luc, G.4
Ziegler, O.5
Dachet, C.6
Bruckert, E.7
Douste-Blazy, P.8
Drouin, P.9
Jacotot, B.10
-
34
-
-
0032923831
-
Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: Additive effects of combination treatment on lipid regulation
-
(1999)
Metabolism
, vol.48
, pp. 47-54
-
-
Zambon, D.1
Ros, E.2
Rodriguez-Villar, C.3
Laguna, J.C.4
Vazquez, M.5
Sanllehy, C.6
Casals, E.7
Sol, J.M.8
Hernandez, G.9
-
36
-
-
0030588733
-
Effects of regular and extendedrelease gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels
-
(1996)
Atherosclerosis
, vol.127
, pp. 113-122
-
-
Schaefer, E.J.1
Lamon-Fava, S.2
Cole, T.3
Sprecher, D.L.4
Cilla, D.D.J.5
Balagtas, C.C.6
Rowan, J.P.7
Black, D.M.8
-
37
-
-
8944252340
-
Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice
-
(1996)
J Clin Invest
, vol.97
, pp. 2408-2416
-
-
Berthou, L.1
-
38
-
-
0034705071
-
CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors
-
(2000)
Circulation
, vol.101
, pp. 2411-2417
-
-
Chinetti, G.1
-
39
-
-
0035138625
-
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
-
(2001)
Nat Med
, vol.7
, pp. 53-58
-
-
Chinetti, G.1
-
40
-
-
0034595980
-
Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
-
(2000)
J Biol Chem
, vol.275
, pp. 16638-16642
-
-
Guerre-Millo, M.1
-
41
-
-
0034182779
-
Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects
-
(2000)
Diabetologia
, vol.43
, pp. 673-680
-
-
Flavell, D.M.1
-
42
-
-
0033625985
-
Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease
-
(2000)
Diabetes Metab
, vol.26
, pp. 393-401
-
-
Lacquemant, C.1
Lepretre, F.2
Pineda, T.I.3
Manraj, M.4
Charpentier, G.5
Ruiz, J.6
Staels, B.7
Froguel, P.8
-
43
-
-
0031733038
-
Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes: Role of the peroxisome proliferator-activated receptor-alpha
-
(1998)
Thromb Haemost
, vol.80
, pp. 942-948
-
-
Kockx, M.1
Princen, H.M.2
Kooistra, T.3
-
44
-
-
0032076207
-
Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia
-
(1998)
Atherosclerosis
, vol.138
, pp. 217-225
-
-
Durrington, P.N.1
Mackness, M.I.2
Bhatnagar, D.3
Julier, K.4
Prais, H.5
Arrol, S.6
Morgan, J.7
Wood, G.N.8
-
45
-
-
0030695967
-
Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients
-
(1997)
Thromb Haemost
, vol.78
, pp. 1167-1172
-
-
Kockx, M.1
De Maat, M.P.2
Knipscheer, H.C.3
Kastelein, J.J.4
Kluft, C.5
Princen, H.M.6
Kooistra, T.7
-
46
-
-
0033134791
-
Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha
-
(1999)
Blood
, vol.93
, pp. 2991-2998
-
-
Kockx, M.1
Gervois, P.2
Poulain, P.3
Derudas, B.4
Peters, J.M.5
Gonzales, F.J.6
Princen, H.M.7
Kooistra, T.8
Staels, B.9
-
47
-
-
0035895313
-
PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages
-
(2001)
Circulation
, vol.103
, pp. 207-212
-
-
Neve, B.P.1
Corseaux, D.2
Chinetti, G.3
Zawadzki, C.4
Fruchart, J.C.5
Duriez, P.6
Staels, B.7
Jude, B.8
-
48
-
-
0027241856
-
The pathogenesis of atherosclerosis: A perspective for the 1990s
-
(1993)
Nature
, vol.362
, pp. 801-809
-
-
Ross, R.1
-
50
-
-
0032560545
-
Expression of the peroxisome proliferator-activated receptor gamma (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 7614-7619
-
-
Ricote, M.1
Huang, J.2
Fajas, L.3
Li, A.4
Welch, J.5
Najib, J.6
Witztum, J.L.7
Auwerx, J.8
Palinski, W.9
Glass, C.K.10
-
51
-
-
0032475922
-
Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages
-
(1998)
J Biol Chem
, vol.273
, pp. 25573-25580
-
-
Chinetti, G.1
Griglio, S.2
Antonucci, M.3
Torra, I.P.4
Delerive, P.5
Majd, Z.6
Fruchart, J.C.7
Chapman, J.8
Najib, J.9
Staels, B.10
-
54
-
-
0032565868
-
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
-
(1998)
Nature
, vol.393
, pp. 790-793
-
-
Staels, B.1
-
55
-
-
0033527569
-
Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1
-
(1999)
J Biol Chem
, vol.274
, pp. 32048-32054
-
-
Delerive, P.1
De Bosscher, K.2
Besnard, S.3
Vanden Berghe, W.4
Peters, J.M.5
Gonzalez, F.J.6
Fruchart, J.C.7
Tedgui, A.8
Haegeman, G.9
Staels, B.10
-
56
-
-
0342506477
-
Prevention of the angiographic progression of coronary and veingraft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol
-
Lipid Coronary Angiography Trial (LOCAT) Study Group
-
(1997)
Circulation
, vol.96
, pp. 2137-2143
-
-
Frick, M.H.1
Syvanne, M.2
Nieminen, M.S.3
Kauma, H.4
Majahalme, S.5
Virtanen, V.6
Kesaniemi, Y.A.7
Pasternack, A.8
Taskinen, M.R.9
-
57
-
-
0032506254
-
Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol
-
(1998)
Circulation
, vol.98
, pp. 1993-1999
-
-
Syvanne, M.1
Nieminen, M.S.2
Frick, M.H.3
Kauma, H.4
Majahalme, S.5
Virtanen, V.6
Kesaniemi, Y.A.7
Pasternack, A.8
Ehnholm, C.9
Taskinen, M.R.10
-
61
-
-
0032533219
-
Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)
-
(1998)
J Am Coll Cardiol
, vol.32
, pp. 1648-1656
-
-
Ruotolo, G.1
Ericsson, C.G.2
Tettamanti, C.3
Karpe, F.4
Grip, L.5
Svane, B.6
Nilsson, J.7
De Faire, U.8
Hamsten, A.9
-
65
-
-
0342651348
-
The Diabetes Atherosclerosis Intervention Study (DAIS): A study conducted in cooperation with the World Health Organization. The DAIS Project Group
-
(1996)
Diabetologia
, vol.39
, pp. 1655-1661
-
-
Steiner, G.1
|